BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 31165788)

  • 1. Pathobiology of inherited biliary diseases: a roadmap to understand acquired liver diseases.
    Fabris L; Fiorotto R; Spirli C; Cadamuro M; Mariotti V; Perugorria MJ; Banales JM; Strazzabosco M
    Nat Rev Gastroenterol Hepatol; 2019 Aug; 16(8):497-511. PubMed ID: 31165788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. β-Catenin and interleukin-1β-dependent chemokine (C-X-C motif) ligand 10 production drives progression of disease in a mouse model of congenital hepatic fibrosis.
    Kaffe E; Fiorotto R; Pellegrino F; Mariotti V; Amenduni M; Cadamuro M; Fabris L; Strazzabosco M; Spirli C
    Hepatology; 2018 May; 67(5):1903-1919. PubMed ID: 29140564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathophysiology of cholangiopathies.
    Strazzabosco M; Fabris L; Spirli C
    J Clin Gastroenterol; 2005 Apr; 39(4 Suppl 2):S90-S102. PubMed ID: 15758666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of the bile ducts: essentials for the clinical hepatologist.
    Strazzabosco M; Fabris L
    J Hepatol; 2012 May; 56(5):1159-1170. PubMed ID: 22245898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The intrahepatic cholangiopathies.
    Birnbaum A; Suchy FJ
    Semin Liver Dis; 1998; 18(3):263-9. PubMed ID: 9773426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging concepts in biliary repair and fibrosis.
    Fabris L; Spirli C; Cadamuro M; Fiorotto R; Strazzabosco M
    Am J Physiol Gastrointest Liver Physiol; 2017 Aug; 313(2):G102-G116. PubMed ID: 28526690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. β-Catenin-NF-κB-CFTR interactions in cholangiocytes regulate inflammation and fibrosis during ductular reaction.
    Hu S; Russell JO; Liu S; Cao C; McGaughey J; Rai R; Kosar K; Tao J; Hurley E; Poddar M; Singh S; Bell A; Shin D; Raeman R; Singhi AD; Nejak-Bowen K; Ko S; Monga SP
    Elife; 2021 Oct; 10():. PubMed ID: 34609282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Cholangiopathies.
    Lazaridis KN; LaRusso NF
    Mayo Clin Proc; 2015 Jun; 90(6):791-800. PubMed ID: 25957621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholangiopathies - Towards a molecular understanding.
    Tam PKH; Yiu RS; Lendahl U; Andersson ER
    EBioMedicine; 2018 Sep; 35():381-393. PubMed ID: 30236451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New insights on the role of vascular endothelial growth factor in biliary pathophysiology.
    Mariotti V; Fiorotto R; Cadamuro M; Fabris L; Strazzabosco M
    JHEP Rep; 2021 Jun; 3(3):100251. PubMed ID: 34151244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of liver repair mechanisms in Alagille syndrome and biliary atresia reveals a role for notch signaling.
    Fabris L; Cadamuro M; Guido M; Spirli C; Fiorotto R; Colledan M; Torre G; Alberti D; Sonzogni A; Okolicsanyi L; Strazzabosco M
    Am J Pathol; 2007 Aug; 171(2):641-53. PubMed ID: 17600123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathology and pathogenesis of intrahepatic bile duct loss.
    Nakanuma Y; Tsuneyama K; Harada K
    J Hepatobiliary Pancreat Surg; 2001; 8(4):303-15. PubMed ID: 11521175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammation and the Gut-Liver Axis in the Pathophysiology of Cholangiopathies.
    Giordano DM; Pinto C; Maroni L; Benedetti A; Marzioni M
    Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30275402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The dynamic biliary epithelia: molecules, pathways, and disease.
    O'Hara SP; Tabibian JH; Splinter PL; LaRusso NF
    J Hepatol; 2013 Mar; 58(3):575-82. PubMed ID: 23085249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bile acid receptors in the biliary tree: TGR5 in physiology and disease.
    Deutschmann K; Reich M; Klindt C; Dröge C; Spomer L; Häussinger D; Keitel V
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1319-1325. PubMed ID: 28844960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibropolycystic liver disease: CT and MR imaging findings.
    Brancatelli G; Federle MP; Vilgrain V; Vullierme MP; Marin D; Lagalla R
    Radiographics; 2005; 25(3):659-70. PubMed ID: 15888616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging of fibropolycystic liver disease.
    Sharbidre K; Zahid M; Venkatesh SK; Bhati C; Lalwani N
    Abdom Radiol (NY); 2022 Jul; 47(7):2356-2370. PubMed ID: 35670875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathophysiologic implications of innate immunity and autoinflammation in the biliary epithelium.
    Strazzabosco M; Fiorotto R; Cadamuro M; Spirli C; Mariotti V; Kaffe E; Scirpo R; Fabris L
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1374-1379. PubMed ID: 28754453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Congenital cystic diseases of the intra and extrahepatic bile ducts].
    Dhumeaux D
    Gastroenterol Clin Biol; 2005; 29(8-9):878-82. PubMed ID: 16294162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrophage recruitment by fibrocystin-defective biliary epithelial cells promotes portal fibrosis in congenital hepatic fibrosis.
    Locatelli L; Cadamuro M; Spirlì C; Fiorotto R; Lecchi S; Morell CM; Popov Y; Scirpo R; De Matteis M; Amenduni M; Pietrobattista A; Torre G; Schuppan D; Fabris L; Strazzabosco M
    Hepatology; 2016 Mar; 63(3):965-82. PubMed ID: 26645994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.